256 related articles for article (PubMed ID: 18256529)
21. The Ewing's sarcoma fusion protein, EWS-FLI, binds Runx2 and blocks osteoblast differentiation.
Li X; McGee-Lawrence ME; Decker M; Westendorf JJ
J Cell Biochem; 2010 Nov; 111(4):933-43. PubMed ID: 20665663
[TBL] [Abstract][Full Text] [Related]
22. Interference with the constitutive activation of ERK1 and ERK2 impairs EWS/FLI-1-dependent transformation.
Silvany RE; Eliazer S; Wolff NC; Ilaria RL
Oncogene; 2000 Sep; 19(39):4523-30. PubMed ID: 11002425
[TBL] [Abstract][Full Text] [Related]
23. Development of Ewing's sarcoma from primary bone marrow-derived mesenchymal progenitor cells.
Riggi N; Cironi L; Provero P; Suvà ML; Kaloulis K; Garcia-Echeverria C; Hoffmann F; Trumpp A; Stamenkovic I
Cancer Res; 2005 Dec; 65(24):11459-68. PubMed ID: 16357154
[TBL] [Abstract][Full Text] [Related]
24. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
[TBL] [Abstract][Full Text] [Related]
25. The splicing factor U1C represses EWS/FLI-mediated transactivation.
Knoop LL; Baker SJ
J Biol Chem; 2000 Aug; 275(32):24865-71. PubMed ID: 10827180
[TBL] [Abstract][Full Text] [Related]
26. Transformation induced by Ewing's sarcoma associated EWS/FLI-1 is suppressed by KRAB/FLI-1.
Chan D; Wilson TJ; Xu D; Cowdery HE; Sanij E; Hertzog PJ; Kola I
Br J Cancer; 2003 Jan; 88(1):137-45. PubMed ID: 12556973
[TBL] [Abstract][Full Text] [Related]
27. Small-molecule screen identifies modulators of EWS/FLI1 target gene expression and cell survival in Ewing's sarcoma.
Boro A; Prêtre K; Rechfeld F; Thalhammer V; Oesch S; Wachtel M; Schäfer BW; Niggli FK
Int J Cancer; 2012 Nov; 131(9):2153-64. PubMed ID: 22323082
[TBL] [Abstract][Full Text] [Related]
28. BCL11B is up-regulated by EWS/FLI and contributes to the transformed phenotype in Ewing sarcoma.
Wiles ET; Lui-Sargent B; Bell R; Lessnick SL
PLoS One; 2013; 8(3):e59369. PubMed ID: 23527175
[TBL] [Abstract][Full Text] [Related]
29. EWS/FLI-l peptide-pulsed dendritic cells induces the antitumor immunity in a murine Ewing's sarcoma cell model.
Peng W; Huang X; Yang D
Int Immunopharmacol; 2014 Aug; 21(2):336-41. PubMed ID: 24861249
[TBL] [Abstract][Full Text] [Related]
30. Genetically defined EWS/FLI1 model system suggests mesenchymal origin of Ewing's family tumors.
Potikyan G; France KA; Carlson MR; Dong J; Nelson SF; Denny CT
Lab Invest; 2008 Dec; 88(12):1291-302. PubMed ID: 18838963
[TBL] [Abstract][Full Text] [Related]
31. Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma.
Ban J; Jug G; Mestdagh P; Schwentner R; Kauer M; Aryee DN; Schaefer KL; Nakatani F; Scotlandi K; Reiter M; Strunk D; Speleman F; Vandesompele J; Kovar H
Oncogene; 2011 May; 30(18):2173-80. PubMed ID: 21217773
[TBL] [Abstract][Full Text] [Related]
32. Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma.
Stegmaier K; Wong JS; Ross KN; Chow KT; Peck D; Wright RD; Lessnick SL; Kung AL; Golub TR
PLoS Med; 2007 Apr; 4(4):e122. PubMed ID: 17425403
[TBL] [Abstract][Full Text] [Related]
33. A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells.
Girnita L; Girnita A; Wang M; Meis-Kindblom JM; Kindblom LG; Larsson O
Oncogene; 2000 Aug; 19(37):4298-301. PubMed ID: 10980604
[TBL] [Abstract][Full Text] [Related]
34. Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis.
Braun BS; Frieden R; Lessnick SL; May WA; Denny CT
Mol Cell Biol; 1995 Aug; 15(8):4623-30. PubMed ID: 7623854
[TBL] [Abstract][Full Text] [Related]
35. Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis.
Showpnil IA; Miller KR; Taslim C; Pishas KI; Lessnick SL; Theisen ER
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32658189
[TBL] [Abstract][Full Text] [Related]
36. IGF1 is a common target gene of Ewing's sarcoma fusion proteins in mesenchymal progenitor cells.
Cironi L; Riggi N; Provero P; Wolf N; Suvà ML; Suvà D; Kindler V; Stamenkovic I
PLoS One; 2008 Jul; 3(7):e2634. PubMed ID: 18648544
[TBL] [Abstract][Full Text] [Related]
37. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
[TBL] [Abstract][Full Text] [Related]
38. EWS/FLI-1 oncoprotein subtypes impose different requirements for transformation and metastatic activity in a murine model.
González I; Vicent S; de Alava E; Lecanda F
J Mol Med (Berl); 2007 Sep; 85(9):1015-29. PubMed ID: 17453169
[TBL] [Abstract][Full Text] [Related]
39. PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors.
Zwerner JP; May WA
Oncogene; 2001 Feb; 20(5):626-33. PubMed ID: 11313995
[TBL] [Abstract][Full Text] [Related]
40. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes.
Watanabe G; Nishimori H; Irifune H; Sasaki Y; Ishida S; Zembutsu H; Tanaka T; Kawaguchi S; Wada T; Hata J; Kusakabe M; Yoshida K; Nakamura Y; Tokino T
Genes Chromosomes Cancer; 2003 Mar; 36(3):224-32. PubMed ID: 12557222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
